Jonathan Hirsch

Jonathan Hirsch serves as the Chief Strategy and Growth Officer at Paradigm, focusing on enhancing equitable access to clinical trials and reducing the burden on physicians involved in clinical research. In addition to this role, Jonathan co-founded Synapticure Inc. and functions as an investor and advisory board chair there, while also investing in Arbital Health, Frame, Thyme Care, Forta, and other companies. Jonathan advises Viz.ai and Osmind, and provides insights to Freenome as an advisor on Real World Evidence and Data Platforms. With a background in Biological Sciences from Stanford University and degrees in Biology and Political Science from the University of Chicago, Jonathan combines educational expertise with a commitment to building innovative companies in the healthcare sector.